Published in J Mol Cell Cardiol on January 29, 2015
Long noncoding RNA dysregulation in ischemic heart failure. J Transl Med (2016) 0.89
Long noncoding RNAs in diseases of aging. Biochim Biophys Acta (2015) 0.88
So! What's aging? Is cardiovascular aging a disease? J Mol Cell Cardiol (2015) 0.88
Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA. J Biol Chem (2015) 0.87
ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases. Oxid Med Cell Longev (2016) 0.85
MicroRNAs in cardiovascular ageing. J Physiol (2015) 0.82
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep (2016) 0.82
The lncRNA RZE1 Controls Cryptococcal Morphological Transition. PLoS Genet (2015) 0.81
Circulating Long Noncoding RNA UCA1 as a Novel Biomarker of Acute Myocardial Infarction. Biomed Res Int (2016) 0.81
The expression of the BPIFB4 and CXCR4 associates with sustained health in long-living individuals from Cilento-Italy. Aging (Albany NY) (2017) 0.81
LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR. Nucleic Acids Res (2016) 0.80
miRiaD: A Text Mining Tool for Detecting Associations of microRNAs with Diseases. J Biomed Semantics (2016) 0.77
Epigenetic regulation in heart failure. Curr Opin Cardiol (2016) 0.76
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq. Sci Rep (2016) 0.76
LncRNA mediated regulation of aging pathways in Drosophila melanogaster during dietary restriction. Aging (Albany NY) (2016) 0.76
Role of miR-145 in chronic constriction injury in rats. Exp Ther Med (2016) 0.75
Identification of the lncRNA, AK156230, as a novel regulator of cellular senescence in mouse embryonic fibroblasts. Oncotarget (2016) 0.75
The Long Noncoding RNA Landscape of the Ischemic Human Left Ventricle. Circ Cardiovasc Genet (2017) 0.75
Long Non-Coding RNAs: A Novel Paradigm for Toxicology. Toxicol Sci (2016) 0.75
Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy. Ann Transl Med (2016) 0.75
Expression profiling and functional annotation of noncoding genes across 11 distinct organs in rat development. Sci Rep (2016) 0.75
Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence. PLoS One (2017) 0.75
Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population. Sci Rep (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 20.59
Landscape of transcription in human cells. Nature (2012) 20.18
The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet (2010) 15.87
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell (2005) 12.73
Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (2007) 12.08
Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem (2010) 12.06
MicroRNA-133 controls cardiac hypertrophy. Nat Med (2007) 11.68
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature (2008) 10.73
p53 mutant mice that display early ageing-associated phenotypes. Nature (2002) 10.05
Treatment of HCV infection by targeting microRNA. N Engl J Med (2013) 9.91
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A (2008) 9.86
Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A (2004) 9.25
A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell (2011) 9.24
Serum microRNAs are promising novel biomarkers. PLoS One (2008) 8.69
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
The essence of senescence. Genes Dev (2010) 8.21
Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 8.04
Long noncoding RNAs and human disease. Trends Cell Biol (2011) 7.59
Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol (2014) 7.41
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation (2003) 7.40
Four faces of cellular senescence. J Cell Biol (2011) 6.86
The microRNA spectrum in 12 body fluids. Clin Chem (2010) 6.82
Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol (2005) 6.34
Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28
Pervasive roles of microRNAs in cardiovascular biology. Nature (2011) 6.08
lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature (2011) 5.42
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
Epigenetic regulation by long noncoding RNAs. Science (2012) 4.74
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 4.47
Functional screening identifies miRNAs inducing cardiac regeneration. Nature (2012) 4.39
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest (2009) 4.39
The multilayered complexity of ceRNA crosstalk and competition. Nature (2014) 4.15
Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation (2002) 4.12
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet (2007) 4.09
MicroRNA-34a regulates cardiac ageing and function. Nature (2013) 4.03
miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res (2008) 3.96
The noncoding RNA revolution-trashing old rules to forge new ones. Cell (2014) 3.87
LincRNA-p21 suppresses target mRNA translation. Mol Cell (2012) 3.87
Conserved metabolic regulatory functions of sirtuins. Cell Metab (2008) 3.86
MiR423-5p as a circulating biomarker for heart failure. Circ Res (2010) 3.83
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet (2010) 3.75
Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (2011) 3.74
Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci (2000) 3.70
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation (2003) 3.62
Acute myocardial infarction. Lancet (2008) 3.59
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res (2009) 3.53
Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res (2002) 3.51
Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun (2009) 3.49
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev (2000) 3.40
Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol (2012) 3.20
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation (2009) 3.19
Long noncoding RNAs: past, present, and future. Genetics (2013) 3.16
MicroRNA and cancer. Mol Oncol (2012) 3.10
Autophagy and aging: keeping that old broom working. Trends Genet (2008) 3.09
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther (2009) 3.05
Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci U S A (2004) 3.00
Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation (2012) 2.95
The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res (2007) 2.92
Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun (2012) 2.90
Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature (2012) 2.63
Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol (2012) 2.62
Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem (2008) 2.60
Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet (2013) 2.59
Gene therapy: twenty-first century medicine. Annu Rev Biochem (2005) 2.59
Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol (2011) 2.56
Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation (2011) 2.52
Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature (2011) 2.47
MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Circulation (2012) 2.36
Vascular cell senescence: contribution to atherosclerosis. Circ Res (2007) 2.32
Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol (2011) 2.31
Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics (2013) 2.27
Aging and arterial stiffness. Circ J (2010) 2.21
SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem (2010) 2.20
A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) (2010) 2.18
Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J (2008) 2.16
Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem (2009) 2.08
Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet (2010) 2.05
MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation (2009) 2.05
Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem (1998) 2.05
Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res (2011) 2.02
Long noncoding RNAs in patients with acute myocardial infarction. Circ Res (2014) 2.02
MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res (2011) 2.01
Assessment of plasma miRNAs in congestive heart failure. Circ J (2010) 2.00
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation (2011) 1.99
MicroRNA-24 regulates vascularity after myocardial infarction. Circulation (2011) 1.98
Increased MKK4 abundance with replicative senescence is linked to the joint reduction of multiple microRNAs. Sci Signal (2009) 1.97
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ Res (2010) 1.96
A long noncoding RNA protects the heart from pathological hypertrophy. Nature (2014) 1.96
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation (2009) 1.92
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun (2012) 1.88
ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol (2010) 1.87
Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol (2012) 1.87
MicroRNA function in neuronal development, plasticity and disease. Biochim Biophys Acta (2008) 1.84
MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell (2011) 1.84
miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ (2011) 1.77
HuD regulates coding and noncoding RNA to induce APP→Aβ processing. Cell Rep (2014) 0.92
Alternative Splicing of Neuronal Differentiation Factor TRF2 Regulated by HNRNPH1/H2. Cell Rep (2016) 0.76